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Abstract. Three-dimensional tumor models have emerged as valuable
in vitro research tools, though the power of such systems as quantita-
tive reporters of tumor growth and treatment response has not been
adequately explored. We introduce an approach combining a 3-D
model of disseminated ovarian cancer with high-throughput process-
ing of image data for quantification of growth characteristics and cy-
totoxic response. We developed custom MATLAB routines to analyze
longitudinally acquired dark-field microscopy images containing
thousands of 3-D nodules. These data reveal a reproducible bimodal
log-normal size distribution. Growth behavior is driven by migration
and assembly, causing an exponential decay in spatial density con-
comitant with increasing mean size. At day 10, cultures are treated
with either carboplatin or photodynamic therapy PDT. We quantify
size-dependent cytotoxic response for each treatment on a nodule by
nodule basis using automated segmentation combined with ratiomet-
ric batch-processing of calcein and ethidium bromide fluorescence
intensity data indicating live and dead cells, respectively. Both treat-
ments reduce viability, though carboplatin leaves micronodules
largely structurally intact with a size distribution similar to untreated
cultures. In contrast, PDT treatment disrupts micronodular structure,
causing punctate regions of toxicity, shifting the distribution toward
smaller sizes, and potentially increasing vulnerability to subsequent
chemotherapeutic treatment. © 2010 Society of Photo-Optical Instrumentation Engi-
neers. DOI: 10.1117/1.3483903
Keywords: ovarian cancer; three-dimensional models; image processing; photody-
namic therapy; carboplatin.
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1 Introduction
Three-dimensional 3-D tumor models have emerged as valu-
able in vitro research platforms to evaluate tumor growth
properties,1–4 and therapeutic response in a more physiologi-
cally relevant manner than monolayer cultures.5–9 In pioneer-
ing studies, the Bissel laboratory established in vitro 3-D
breast cancer models in which normal and malignant breast
epithelial cells grown on a bed of growth-factor-reduced
GFR Matrigel™ form polarized 3-D acinar structures.10
Implementing these 3-D models to understand cell signaling
in relation to position within a acinus, their group and others
were able to make basic tumor biology insights into breast
carcinogenesis and progression, which would not be possible
in monolayer cultures.1–4 Treatment response studies have
shown that cancer cells induced to form 3-D spheroids are
vastly less sensitive to chemotherapy than monolayer cells.5
Finlay et al.,6 Bigelow et al.,7 Georgakoudi and Foster,8 and
Foster et al.,9 also demonstrated the utility of tumor spheroids
to study dose rate effects and other key determinants of pho-
todynamic therapy PDT efficacy. While these reports dem-
onstrate the importance of restoring key architectural cues in
vitro, the full capability of 3-D tumor models as a biologically
relevant platform for analysis of tumor growth and cytotoxic
response has not yet been adequately explored. In vitro 3-D
tumor systems, could, with the appropriate statistical charac-
terization methods, be used as tools to provide a window into
tumor growth mechanisms in vivo, while providing a level of
access for imaging and manipulation of the system that is
difficult to achieve in animal models. Similarly, 3-D models
provide a unique but untapped opportunity to quantify cyto-
toxic response across large numbers of individual tumor nod-
ules of different sizes in a system where physical variables
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such as penetration of drugs through multiple cell layers ac-
tually reflect the physiological scenario.
To tap into the inherent capability of in vitro 3-D systems
as reporters of growth properties and cytotoxic response, op-
tical microscopy emerges as a natural research tool. Cultures
can be plated on coverslip bottom dishes or multiwell plates
to allow for imaging with an inverted microscope, which re-
quires no disruption of the sample and is highly conducive to
longitudinal monitoring. In contrast to previous studies exam-
ining cellular-level signaling in high-resolution images of
single acini,1–4 here we focus on quantification of large data
sets, by acquisition of microscope fields each containing hun-
dreds of tumor nodules. Model systems such as those just
described, in which cells are overlaid on a basement mem-
brane layer, are particularly conducive to this type of imaging
as 3-D structures are formed in a single focal plane on the
surface of the gel as opposed to being embedded inside it.
These fields can then be automatically segmented and batch
processed to obtain lists of sizes, eccentricities, and positions
for each nodule. By acquiring sets of images across indepen-
dently prepared cultures at sequences of time points, evolu-
tion of the full size distribution rather than just representative
measurements for thousands of 3-D structures can be moni-
tored. Similarly, by using the appropriate fluorescence agents
to stain live and dead cells following cytotoxic treatments,
2-D arrays of pixel data can again be segmented to report
treatment response nodule by nodule, correlating viability
with structural or morphological changes in response to treat-
ment. With appropriate ratiometric quantification, this ap-
proach provides a level of sophistication in reporting of cyto-
toxic response that cannot be achieved with traditional
colorimetric assays in which the viability of an entire culture
dish is reduced to a single number.
In this paper, we utilize this imaging-based approach to
elucidate growth characteristics and patterns of cytotoxic re-
sponse in an in vitro 3-D model of micrometastatic ovarian
cancer. For the majority of patients, this disease is diagnosed
at a late stage characterized by disseminated studding of the
peritoneal surfaces with tumor nodules ranging in size from
microscopic clusters of a few cells to large cakes of disease
spanning several centimeters.11–13 The low survival rate of
31%, which has improved only marginally over the course of
decades, points to the need for new physiologically relevant
research platforms to meaningfully examine treatment re-
sponse and devise more effective strategies. We adopt an ova-
rian cancer model that draws on the established in vitro mod-
els of breast cancer in which cells overlaid on a bed of GFR
Matrigel basement membrane spontaneously form 3-D
acini.1,4,10,14,15 In contrast to 3-D ovarian spheroids, which are
grown in rotary culture to prevent adhesion to the underlying
substrate,16,17 this system recapitulates the spontaneous forma-
tion of tumor nodules from individual adherent cells. Follow-
ing a characterization of the growth kinetics in this system,
we examine the response to two mechanistically distinct treat-
ments: carboplatin and PDT. Carboplatin is an established
chemotherapy in clinical use for the treatment of ovarian
cancer.18,19 PDT is a light-based therapy in which wavelength-
specific activation of a photosensitizer generates cytotoxicity
to the illuminated region.20 PDT has demonstrated promise
for treatment of ovarian cancer in clinical and preclinical
studies, though additional studies are required to establish op-
timal treatment parameters.21–26
2 Materials and Methods
2.1 Three-Dimensional Cell Culture
Epithelial ovarian cancer NIH:OVCAR-5 cells were obtained
from Thomas Hamilton Fox Chase Cancer Institute, Philadel-
phia, Pennsylvania. The cells were grown in RPMI-1640
Roswell Park Memorial Institute medium Mediatech Inc.,
Herndon, Virginia, USA supplemented with 10% heat-
inactivated fetal calf serum GIBCO Life Technologies,
Grand Island, New York, USA, 100 U /mL penicillin, and
100 g /mL streptomycin. For 3-D cell culture, growth factor
reduced GFR Matrigel BD Biosciences, San Jose, Califor-
nia was used as a basement membrane, which has appropri-
ate gel structure and established biological activity to promote
growth and differentiation of a variety of cells.27 To prepare
3-D cultures 500-L volumes of NIH:OVCAR-5 cells in
single cell suspension of 15,000 cells /mL were grown on
beds of GFR Matrigel BD Biosciences on the glass slide
inset of 35-mm MatTek culture dishes MatTek Corporation,
Ashland, Massachusetts, USA. GFR Matrigel beds were ini-
tially prepared by ejecting 150 L of GFR Matrigel solution
at 4 °C on the chilled MatTek plates and carefully rotating
the dish at a slight angle to evenly distribute it over the
10-mm-radius glass portion of the MatTek dishes that were
then incubated at 37 °C for 30 min prior to plating cells to
allow gelation to occur. Following initial plating of cells, they
were allowed to adhere to the Matrigel bed before addition of
complete growth medium with 2% GFR Matrigel. All cultures
were maintained in an incubator at 37 °C in an atmosphere of
5% CO2.
2.2 Microscopy for Growth Characterization
To characterize development of size distributions over time,
3-D cultures were routinely imaged by darkfield microscopy
at 5 using a Zeiss Axiovert inverted microscope Carl Zeiss
MicroImaging, Inc., Thornwood, NY, USA fitted with a
QuantiFIRE™ cooled 12-bit monochrome CCD camera with
2048 2048-pixel chip Optronics, Goleta, California. Im-
ages were acquired in a focal plane just above the surface of
the gel on which 3-D structures are formed. For each plate,
five dark-field images of each culture dish were acquired at
each time point in the tagged image file format TIFF and
saved for off-line processing. Time-lapse microscopy se-
quences were obtained using a Nikon TE2000-S inverted mi-
croscope with a 10 phase contrast objective in an enclosed
weather station Nikon Instruments, Inc, Melville, New York,
USA.
2.3 Image Processing for Growth Analysis
Image data was processed using custom scripts developed us-
ing the Image Processing Toolbox in the MATLAB software
package Mathworks, Natick, Massachusetts, USA. To calcu-
late size distributions from image data we developed a batch
analysis routine in which sets of high-contrast dark-field im-
ages were thresholded calling on a built-in automated routine
based on Otsu’s method, made binary and segmented to iden-
tify in vitro nodules. The routine would count the number of
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pixels in each region while rejecting partial features at the
edge of each field of view and calibrate sizes to square mi-
crometers. Features of size less than 200 m2 were rejected.
Lists of statistics for each feature size in square micrometers,
equivalent diameter in micrometers, eccentricity, and the x
and y positions in the image were tabulated and grouped by
time point. Size distribution histograms were then generated
from lists of sizes at each time point. In general we report size
in units of square micrometers as 2-D cross-sectional area A,
which is directly reported from calibration of pixel counts,
and strictly speaking, is the most accurate quantification of
size. However, nodules are approximately spherical and it is a
reasonable approximation to calculate equivalent diameter deq
as a more intuitive metric of nodule size, which is obtained
from area by deq /22=A.
Image data were grouped into directories by imaging time
point so that all routines were run as batch processes, enabling
rapid generation of statistics on large lists of micronodules at
each time point. The same automated segmentation approach
was used to analyze the size distribution of residual viable
disease following treatment by application of the same batch
process to sets of calcein green fluorescence image data, as
described in the following. To verify the accuracy and preci-
sion of high-throughput automated image segmentation ap-
proximately 1 out of every 50 images was randomly selected
for manual verification by having MATLAB overlay arrows at
each software-identified nodule centroid. This comparison of
manual identification to software identification in the images
tested revealed a 97.3% rate of agreement for positive identi-
fication of features. Additional data analysis and graphing of
image data including multipeak nonlinear least-squares
Gaussian curve fits was conducted using the Origin software
package OriginLab Corporation, Northampton, Massachu-
setts.
2.4 Carboplatin Treatments
Carboplatin treatments were performed by incubating 3-D
cultures in OVCAR-5 complete culture medium with 1 mM
carboplatin Teva Pharmaceuticals, Petach Tikva, Israel for a
total of 96 h, including a carboplatin media refresh at 48 h.
This dose was selected based on calculation of the concentra-
tion with respect to the area of the culture dish to provide a
dosage estimated to be equivalent to the clinical dose of
400 mg /m2, which was reported to be effective in human
patients.18 Treatment response was assessed immediately after
removal of carboplatin media as described in the following.
2.5 PDT Treatments
At day 10 following plating, cultures were incubated with
250 nM BPD-MA or Verteporfin, QLT, Inc., Vancouver, Brit-
ish Columbia, Canada in complete culture media for 90 min.
Immediately prior to irradiation, the media were replaced with
regular complete media. Laser irradiation was delivered
through the bottom of each culture dish on a clear plastic tray
via a vertically mounted Thorlabs FT600EMT multimode fi-
ber Thorlabs, Newton, New Jersey, USA, which was colli-
mated to overfill the dish area to deliver light nearly uni-
formly over the central 1-cm-radius portion of a MatTek dish
containing the Matrigel layer with 3-D nodules on the surface.
Irradiation times were calculated to achieve total fluence of
10 J /cm2 at a fluence rate of 50 mW /cm2, which was mea-
sured using an Ophir Vega power meter with photodiode sen-
sor Ophir Optronics, Israel prior to each experiment. After
treatments, cultures were returned to the incubators for 24 h
prior to assessment of treatment response.
2.6 Imaging-Based Assessment of Cytotoxic Response
Assessment of cytotoxic response in the 3-D culture model
posed an additional challenge as the conversion products from
traditional MTT and MTS assays were found to adhere to the
Matrigel substrate preventing reliable reporting of viability by
these methods. To overcome this we developed a quant-
itative fluorescence-imaging-based approach using the
LIVE/DEAD® cytotoxicity kit Invitrogen Corporation, Carls-
bad, California, USA. Media was removed from culture
dishes of 3-D nodules by gentle aspiration followed by a wash
with phosphate-buffered saline PBS and incubation at
37 °C for 40 min with 2 M calcein AM and 4 M
ethidium homodimer-1 Invitrogen diluted in PBS prior to
imaging. Addition of reagents to each culture dish was stag-
gered such that the incubation period was exactly 40 min for
each dish. Following incubation, three digital images were
acquired by sequentially rotating filter cubes on a Zeiss Axio-
vert 100 TV inverted microscope Zeiss, Germany at each of
four spatial fields imaged in each culture dish: 1 a dark-field
image, 2 a calcein fluorescence emission image
494 /517 nm, excitation/emission, and 3 an ethidium bro-
mide fluorescence emission image 528 /617 nm excitation/
emission on intercalation into DNA. All images were ac-
quired using a 5 objective in inverted geometry imaging
through the glass window on the bottom of each MatTek cul-
ture dish and collecting light from the focal plane on which
3-D cultures were grown on the surface of the Matrigel bed.
Images were captured with a CCD camera Quantifire XI,
Optronix, Israel and saved as 12-bit TIFFs for later analysis.
Again, using a batch-process routine developed in the MAT-
LAB software package, sets of images were analyzed in high
throughput to report the mean fluorescence signal from the
calcein and ethidium bromide channels with the ratio of cal-
cein fluorescence to total fluorescence calcein plus ethidium
as a reporter of viability. The ratio was computed in this man-
ner for all treatment groups. To make comparisons between
carboplatin and PDT treatments assessed at different imaging
sessions, values were normalized to the respective no-
treatment control group to calculate percentage viability for
each treatment following standard general practice for quan-
tification of cytotoxic response by any method. This routine
was then run inside the size distribution code already dis-
cussed to identify each nodule in a corresponding dark-field
image of a given field and then calculate the viability based
only on the pixels in that nodule. Iterating over all in vitro
nodules, this method produces lists of hundreds of nodules for
each treatment group for each experimental run, and viability
for each one.
2.7 Immunofluorescence Protocol
The 3-D cultures were stained following a protocol previously
described by Debnath and Brugge.1 To prevent the degrada-
tion of the Matrigel during the staining protocol and subse-
quent loss of 3-D nodules from the Matrigel surface, culture
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dishes were maintained at 37 °C between all steps. The ex-
change of buffers and staining solutions was accomplished
using a micropipetter to minimize disruption of the Matrigel.
Anti-E-cadherin antibodies BD Transduction Laboratories,
BD Bioseciences, San Jose, California, USA were conju-
gated with Alexa Fluor 568 labeled goat antimouse Invitro-
gen for targeted E-cadherin molecular imaging. DAPI
4 ,6-diamidino-2-phenylindole was obtained from Sigma
and diluted accordingly. Images were obtained using an
Olympus FV1000 confocal microscope Olympus of America,
Inc., Center Valley, Pennsylvania, USA.
3 Results and Discussion
3.1 Growth Characterization
OVCAR-5 human ovarian cancer cells plated on GFR Matri-
gel formed solid, multicellular 3-D acini that reached sizes of
the order of 110 m in diameter by 10 days following plat-
ing, consistent with previously reported observations from op-
tical coherence tomography OCT imaging of individual
nodules plated by the same method.28 We observed that the
physical characteristics of the 3-D acini Fig. 1 was highly
varied, with structures ranging from clusters of just a few
cells to large acini to caked aggregates of multiple acini,
qualitatively resembling the heterogeneity of micronodular
disease in vivo.23 To quantify growth kinetics in this system,
multiple independently plated batches were longitudinally im-
aged by dark-field microscopy providing high-contrast im-
ages conducive to processing at regular intervals for up to
24 days following initial plating. To obtain statistically sig-
nificant data sets, large fields of view containing initially of
the order 200 cells were obtained using a 5 objective. For
each independently plated culture, five fields of view were
obtained for each time point and saved into directories orga-
nized by time point. Using image processing routines devel-
oped in the MATLAB software package, we batch-processed
these large sets of dark-field microscopy image data to pro-
duce lists of statistics for thousands of individual 3-D acini at
multiple time points. We observed that the distribution of aci-
nar sizes was initially homogeneous through days 3 to 4, but
consistently broadened at late time points with a significant
fraction of acini with sizes from 200 to 400 m2 in cross-
sectional area from 2-D microscopy data but with numerous
larger acini with sizes up to 400,000 m2. As this skewed
distribution of sizes suggested a log-normal distribution we
generated histograms for each time point with logarithmically
base 2 spaced bins Fig. 1 consistent with the basic premise
that growth processes are driven by multiplicative, rather than
additive events.29 In these histograms, we consistently ob-
served the emergence of two log-normal modes at later time










exp− s − sc22
w2
2  , 1
where
s = log2 s100 , 2
and A, w, and sc are amplitude, width, and center position of
each peak, respectively. This bimodal form indicates the pres-
ence of two distinct growth behaviors. These distinct growth
modes correspond to a population of cells in which Sc1 re-
mains constant over time, corresponding to a constant equiva-
lent diameter of 20 m over the time probed. The other
peak, with position Sc2, shifts to the right at subsequent im-
aging time points corresponds to a more rapidly assembling
Fig. 1 Representative dark-field microscopy images of in vitro 3-D
acini and corresponding size distribution histograms and Gaussian fits
from analysis of image data obtained at a day 3 following plating
and b day 7, c day 10, and d day 17. The n values on the right of
each histogram indicate the number of nodules included in each his-
togram. Scale bars=250 m.
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subdistribution of micronodules with mean equivalent diam-
eters deq of 92, 120, and 150 m at days 7, 10, and 17,
respectively 	Figs. 1b–1d
. Extrapolating the constant po-
sition of Sc1 back to the day 3 image data and subjecting it to
the same two-peak model even though the distribution ini-
tially appears to have only one peak, we found that the non-
linear least-squares curve fit rapidly converged, indicating that
this bimodal behavior also describes the early time points fol-
lowing plating. The other fit parameters associated with the
population of the more aggressive growth mode also seem to
have time dependent behavior, with w2 monotonically in-
creasing, while A2 monotonically decreases over the time
probed but with the area under the peak remaining roughly
constant. In contrast, the width and amplitude of the smaller
size peak, w1 and A1, respectively, remain roughly constant.
Size distributions at individual time points were also com-
pared across individual culture dishes and dates of plating,
and no statistically significant systematic variations were ob-
served p value0.1 in two-tailed t test comparison of size
lists between plates. The bimodal distribution was observed
in all dishes with separable peaks observed in approximately
the same positions in all cases with p value0.001 in a two-
tailed Student’s t test comparison of sets of sc1 and sc2 values
calculated from each independently plated culture imaged at a
given time point three to nine cultures depending on the time
point. Conversely, comparison of lists of sc1 values derived
from different time points show no significance p value
0.1, indicating that indeed this peak is reproducibly cen-
tered in the same position, while sc2 shifts significantly be-
tween days 7 and 17 with p value=0.01.
To examine these growth properties in real time, we con-
ducted a series of time-lapse microscopy experiments in
which 3-D cultures grown in multiwell plates were imaged at
10-min intervals over the course of several days. Individual
snapshots from several timepoints of the full sequence are
shown in Fig. 2. Observation of the behavior of individual
cells over an extended period in time lapse sequences sup-
ports the observation of two growth behaviors; one population
of cells rapidly merged together forming larger and larger
multicellular aggregates 	yellow arrows in Fig. 2a exemplify
this behavior
 while another appeared to be dominated by
slow proliferation with little or no evidence of motility and
assembly 	the cell in the green box in Fig. 2a is consistent
with this behavior
. The complete time-lapse sequence from
which these frames were obtained is shown in the video.
These observations give rise to the model shown schemati-
cally in Fig. 2b, indicating a rapidly comigrating group of
cells beige juxtaposed with another group of cells 30% as
indicated from frequency counts above that exhibit little mo-
tility or affinity for assembly with surrounding cells, regard-
less of proximity. The rapid migration and assembly behavior
gives rise to an overall exponential decay in the spatial den-
sity of acini 	Fig. 2c
 that is concomitant with increasing
size 	Fig. 2d
 in the population of larger and more aggres-
sively growing micronodules. It is not surprising that this be-
havior seems to dominate as from the frequency counts in Fig.
2 we would expect 70% of the cells in a given field to
follow the high-motility migration and assembly kinetics. The
decay is of the form nt=n0+A exp−t /, where
=5.9 days−1.
The heterogeneity observed here qualitatively resembles
the distribution of large and small nodules in peritoneal stud-
ding in vivo.23 These highly divergent behaviors, as evidenced
by the differing propensities of the cells to migrate and as-
semble, suggest that even within a single cell line, the 3-D
model reveals heterogeneity in growth properties and possibly
response to treatment that are not apparent in monolayer cul-
tures. Further studies are warranted to correlate these contrast-
ing behaviors with relevant molecular markers and also to
compare distributions of nodular size in this in vitro system
with actual patient tissues. A more complete mathematical
description of the combined aggregation and cell division ki-
netics underlying the formation of multicellular structures in
this 3-D model system is part of an ongoing study.
3.2 Analysis of Carboplatin Treatment Response in
3-D Nodules
To demonstrate the value of our system as a tool to assess
treatment outcome we conducted treatment response studies
with carboplatin, a clinically relevant chemotherapeutic used
to treat ovarian cancer. In preliminary studies, we found that
viability in 3-D could not be assessed by traditional colori-
metric assays as adhesion of the converted products to the
Matrigel substrate obfuscated fluorescence or absorbance
readings correlated with viability. For this reason the commer-
cially available LIVE/DEAD fluorescence imaging kit Invit-
rogen L3224, which stains live cells and dead cells with a
pair of fluorophores calcein and ethidium bromide, with fluo-
rescence emission in the green and red, respectively was
adapted into a quantitative tool to assess cell viability as de-
scribed in Sec. 2. This imaging-based approach for quantita-
tive assessment of cytotoxic response has several valuable
features, as demonstrated in the following. Specifically, be-
cause we have access to a full 2-D array of pixel intensities
rather than a global average we can combine the ratiometric
quantification of viability from fluorescence intensities with
the automated image segmentation used for batch analysis of
size distributions to analyze cytotoxic response nodule by
nodule. This approach provides a depth of insight into pat-
terns of response, by size and morhphology of nodules that
colorimetric assays cannot provide.
Cultures were allowed to grow to day 10 at which time
treatment was initiated. Upon visual inspection of cultures
stained with LIVE/DEAD reagents 	Fig. 3a
 it is apparent
that there is a clear cytotoxic response larger and more in-
tense regions of red ethidium bromide fluorescence relative to
no treatment control. The mean viability of 1000 M
carboplatin-treated nodules reported as live signal divided by
total fluorescence signal and normalized to mean no treatment
control viability was 0.220.07 	minimum 0.073, maximum
0.57 Fig. 3b
. However, even with total exposure to carbo-
platin for an extended incubation period, cytotoxicity seems
to be primarily localized to the cells on the periphery of each
acinus, with large surviving green cores in the center 	Fig.
3a
. This observation is also apparent from analyzing the
size distribution of residual viable disease from segmentation
of the calcein fluorescence emission images 	Fig. 3c
, which
is essentially unchanged from the distribution of nodules prior
to initiation of treatment at day 10 	Fig. 1c
. Size-dependent
treatment response is summarized in Fig. 1d, in which each
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Fig. 2 Characterization and quantification of growth behavior from time lapse microscopy correlated with analysis of longitudinal darkfield image
data shown in Fig. 1. a Individual frames from time-lapse microscopy acquired from 4 h following plating until 4 days following plating the full
time-lapse sequence is included as a video. Yellow arrows indicate clusters of cells that rapidly migrate over the Matrigel surface and assemble to
form larger multicellular acini. The green box indicates a representative cell that does not participate in assembly events in the immediate vicinity,
but does undergo cell division. Scale bars=100 m. b Schematic representation of the bimodal growth kinetics described in Fig. 1 and a.
Approximately 30% of cells gray, exhibit low motility and little potential to migrate toward other clusters of cells. The other 70% of cells beige
cells exhibit a much more aggressive growth behavior, rapidly forming larger and larger multicellular aggregates. The sequential numbering 1, 2,
and 3 in the diagram indicates 1 single cells following plating that 2 form small clusters and 3 subsequently form larger multicellular clusters.
Inset: confocal immunofluorescence section from the center of a nodule fixed and stained for E-cadherin red and DAPI blue at day 10 of growth
to reveal large multicellular 3-D structures formed from assembly and division of individual cells on the gel surface. Scale bar=20 m. c
Assembly events lead to an overall decay in the spatial density of 3-D acini with a decay constant of 5.9 days−1. Error bars in c are standard
deviations of density measurements from five fields, each of three to nine independent prepared culture dishes imaged at a given time point. d
Exponential decay in density is concomitant with an increase in mean diameter over time of rapidly growing nodules corresponding to sc2 from
Gaussian fits in Fig. 1 and Eq. 1 of the text. Mean diameter remains constant in the remaining nodules sc1 in Eq. 1. Error bars in d are derived
from the widths of Gaussian fits shown in Fig. 1. QuickTime, 1.45 MB URL: http://dx.doi.org/10.1117/1.3483903.1.
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data point represents nodule size based on analysis of the
corresponding dark-field channel horizontal axis and the vi-
ability based on the fluorescence intensity ratio calculated
from the pixels in that nodule vertical axis. Following car-
boplatin treatment the size-dependent response appears rela-
tively flat, with all nodules uniformly reduced to a narrowly
distributed range of viabilities. The characteristic bimodal
growth distribution is immediately also evident here from the
two dense clusters of data points to either side of a sparse
region between 1600 and 3200 m2.
The carboplatin treatment response data indicates that al-
though viability is reduced overall, large surviving fractions
of nodules are left behind even after incubation for 4 days
and in a system where the nodules are totally exposed the
agent for the duration of treatment. This could point to a ma-
jor concern in the clinical scenario, where even submillimeter
disseminated disease which our model system reflects re-
mains after chemotherapy and ultimately regrows and devel-
ops drug resistance. This scenario points toward the use of
combination treatment modalities, which enhance the efficacy
of chemotherapy by either improving penetration or increas-
ing the sensitivity of cells prior to treatment.
3.3 Analysis of PDT Treatment Response in 3-D
Nodules
Fluorescence imaging of 3-D cultures subject to 10 J /cm2
BPD-PDT treatment revealed a profoundly different pattern of
response than the chemotherapy treatment Fig. 4. While
some nodules are mostly viable green, others are structurally
degraded with pockets of intense ethidium bromide red fluo-
rescence throughout. Color online only. This pattern is re-
Fig. 3 Carboplatin treatment response assessed by quantitative ratiometric fluorescence imaging. a Representative LIVE/DEAD fluorescence image
of 3-D culture subject to 1000 M carboplatin treatment and corresponding no treatment control grown in identical conditions. The carboplatin
treated plate exhibits a pattern of cytotoxic response in which cores of 3-D nodules remain viable green while cells at the periphery are dead.
Display images adjusted with hi-lo lookup table all quantitative analysis is based on raw unprocessed images. Scale bars=250 m. b Distri-
bution of viabilities in carboplatin treated nodules. Mean viability is 0.22 with standard deviation of 0.07 minimum value 0.073, maximum value
0.57. c Size distribution of residual viable disease based on analysis of green live channel data of carboplatin-treated cultures by the same
methods used in growth characterization as already described. The distribution resembles the untreated cultures at day 10, indicating growth arrest
during treatment, with the mean diameter of larger nodules approximately the same as untreated day 10 cultures. d Combined plot of normalized
viability versus nodule size for 1000 M carboplatin-treated 3-D cultures plotted on the same log scale as c. Each data point corresponds to an
individual 3-D nodule and is obtained by segmentation of the dark-field image to report size and viability based on intensity data from corre-
sponding fluorescence images of the same spatial field. The bimodal size distribution is readily evident from the two dense clusters of data points
to either side of a sparse region between 1600 and 3200 m2.
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flected in the distribution of viabilities of treated nodules nor-
malized to no treatment control 	Fig. 4b
. Which has a mean
value of 0.46 with standard deviation of 0.29 minimum value
0.051, maximum value 1.2. Note that since nodule viabilities
are normalized to the mean of the untreated control viabilities,
it is possible for individual nodules to have a value higher
than 1, even though the average is 46% that of the untreated.
In contrast to carboplatin-treated cultures already described,
in which the size distribution post treatment 	Fig. 3c
 is very
similar to pretreatment 	Fig. 1c
, the size distribution of re-
sidual viable nodules calcein green channel following BPD-
PDT treated cultures is dramatically shifted toward smaller
sized nodules as a result of PDT treatment 	Fig. 4c
. Inte-
gration of the first three histogram bins in Fig. 4c corre-
sponding to sizes from 200 to 1600 m2 nodules up to
45 m in diameter shows that nodules in this size range
account for 68% of the residual disease in the treated culture
dishes as compared to 30% in untreated cultures. This is in
contrast to carboplatin-treated cultures in which the same size
interval accounts for 46% of residual disease, meaning that
more than half of the residual nodules are larger than 45 m
equivalent diameters. To better understand how viability cor-
relates with size for BPD-PDT-treated nodules, normalized
viability is plotted against nodule size 	Fig. 4d
. The vertical
spread in data points corresponding to small nodules indicates
that this population accounts for the overall high degree of
variability. This suggests that as PDT breaks down the larger
nodules, a portion of the small fractions that come off remain
viable. This observation further points to the potential value
of a combination treatment, using PDT to initially disrupt 3-D
nodules, followed by chemotherapy to kill surviving cells.
The trend evident in the scatter plot from the PDT treatment
Fig. 4 Photodynamic therapy treatment response assessed by quantitative ratiometric fluorescence imaging. a Representative LIVE/DEAD fluo-
rescence image of 3-D culture subject to 10 J /cm2 BPD-PDT treatment showing a profoundly different pattern of response than the chemotherapy
treatment Fig. 3. While some nodules are relatively unaffected mostly viable, green, others are structurally degraded with pockets of deep red
fluorescence throughout. Display images adjusted using the hi-lo lookup table all quantitative analysis is based on raw unprocessed images. Scale
bars=250 m. b Distribution of viabilities in 10-J /cm2 BPD-PDT treated nodules. Mean viability is 0.46 with standard deviation of 0.29
minimum value 0.05, maximum value 1.2. c Size distribution of residual viable disease based on analysis of green live channel data of
BPD-PDT treated cultures by the same methods used in growth characterization already described. Although mean viability is higher than in the
case of the 1000 M carboplatin incubation, the distribution is dramatically shifted toward smaller sized nodules. The position of the larger
population peak is shifted to the left with respect to normal growth Fig. 1c or carboplatin incubation Fig. 3c. d Plot of normalized viability
versus nodule size in 10-J /cm2 BPD-PDT treated cultures. Each data point corresponds to an individual 3-D nodule and is obtained by segmen-
tation of the dark-field image to report size and viability based on intensity data from corresponding fluorescence images of the same spatial field.
Size-dependent response exhibits a high degree of scattering in the viabilities of small nodules likely generated by disruption of larger nodules
during PDT treatment.
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response of larger nodules 3000 m2 suggests that there
is a size-dependent trend of increasing viability decreasing
cytotoxicity with increasing nodule size, though additional
studies are warranted to investigate this further. The ability to
make such insights further points to the value of the quanti-
tative imaging-based approach employed in this study to re-
veal urgently required new treatment strategies.
4 Conclusions
We demonstrated the utility of an imaging-based approach for
analysis of tumor growth and treatment response in an in vitro
3-D model of micrometastatic ovarian carcinoma. Using this
system, we introduced a model of the mechanism of growth
for adherent cancer cells on Matrigel based on migration and
assembly behavior that led to the development of a bimodal
size distribution of 3-D nodules. The power of the approach
introduced here is its ability to quantitatively evaluate and
identify statistical trends in growth and cytotoxic response in
distributions of micronodules that physically resemble the
size and structure of tumors in physiological conditions. This
system fills a unique niche in the spectrum of translational
science between traditional monolayer cell culture and animal
models. As demonstrated, our in vitro system is highly con-
ducive to longitudinal imaging, requiring only the removal of
culture dishes from incubation for short periods to place them
on and off the microscope stage. While lacking crucial ele-
ments of in vivo tumor models such as development of vas-
culature, the imaging approach here also provides the ability
to look at thousands of “in vivo-like” nodules simultaneously
without need for anesthesia or endoscopy to obtain access. In
future studies, we plan to further leverage this feature of our
platform by carrying out longitudinal monitoring of the evo-
lution of the micronodular size distribution past the treatment
time point to look at longer term tumor regrowth. This will
provide the ability to examine the impact of new interventions
on tumor regrowth to design new strategies to most effec-
tively target the most persistent disease.
This study utilized our in vitro research platform to pro-
vide new insights into response of micronodular disease to
carboplatin chemotherapy and PDT. While carboplatin re-
duces overall viability, even the 96-h incubation with 1 mM
carboplatin leaves significant surviving fractions. Both the vi-
sual pattern of cell death and the size distribution of residual
viable disease suggests that carboplatin does not penetrate
into the centers of nodules, inducing cell death primarily at
the periphery. In contrast, we find that BPD-PDT treatment
disrupts in vitro nodules, producing a less dramatic reduction
in viability of each nodule, but breaking larger nodules down
into a more fragmented distribution of smaller nodules and
giving rise to a significant change in the size distribution of
residual nodules. These observations suggest the evaluation of
a combination therapy consisting of PDT to initially disrupt
nodules and enhance efficacy of a subsequent carboplatin
treatment.
The imaging-based research platform introduced here pro-
vides a strong foundation to be built on in future studies. The
tumor modeling and imaging tools described could be adapted
to different solid tumor disease models and different treatment
regimens. By incorporation of other cell types such as fibro-
blasts, endothelial cells, and macrophages, models could be
developed that more fully recapitulate tumor stroma interac-
tions. Such models could serve as a physiologically relevant
high-throughput drug screening platform to identify the most
promising agents and sequences prior to more costly in vivo
testing. Furthermore, while this study focused on the evalua-
tion of cytotoxic response to treatment, the quantitative batch
processing of fluorescence image data developed here could
be applied to targeted molecular imaging data. This approach
could incorporate multiple channels of fluorescence input ac-
quired in high throughput with an automated x-y positioning
stage, and the analysis could be adapted for similar quantita-
tive analysis of a broad spectrum of molecular markers in 3-D
nodules. In this manner, changes in expression of relevant
biomarkers could be reported in correlation with statistical
changes in size distribution following treatment, providing the
foundation of mechanism-based combination therapies with
improved outcomes.
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